TREMELIMUMAB

Clinical trials for TREMELIMUMAB explained in plain language.

Never miss a new study

Get alerted when new TREMELIMUMAB trials appear

Sign up with your email to follow new studies for TREMELIMUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy shows promise for Hard-to-Treat liver cancer

Disease control Recruiting now

This study tests a new treatment for people with advanced liver cancer that cannot be removed by surgery. It combines precise proton radiation with two immunotherapy drugs (tremelimumab and durvalumab) to boost the immune system's attack on the tumor. About 45 participants will r…

Matched conditions: TREMELIMUMAB

Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control

Last updated May 26, 2026 10:51 UTC

TREMELIMUMAB

Get alerted when new TREMELIMUMAB trials appear

New combo therapy shows promise for Hard-to-Treat liver cancer